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Theoretical approaches are formulated to investigate the molecular mobility under various cooling
rates of amorphous drugs. We describe the structural relaxation of a tagged molecule as a coupled
process of cage-scale dynamics and collective molecular rearrangement beyond the first coordination
shell. The coupling between local and non-local dynamics behaves distinctly in different substances.
Theoretical calculations for the structural relaxation time, glass transition temperature, and dy-
namic fragility are carried out over twenty-two amorphous drugs and polymers. Numerical results
have a quantitatively good accordance with experimental data and the extracted physical quantities
using the Vogel-Fulcher-Tammann fit function and machine learning. The machine learning method
reveals the linear relation between the glass transition temperature and the melting point, which is a
key factor for pharmaceutical solubility. Our predictive approaches are reliable tools for developing
drug formulation.
I. INTRODUCTION
Amorphous drugs have attracted much attention [1–
5] owing to large solubility and enhanced bioavailabil-
ity compared to the crystalline counterparts. The disor-
dered structure of amorphous pharmaceutical products is
formed by the rapid cooling of the molten material. The
molecular mobility of an amorphous material is charac-
terized by structural (alpha) relaxation time, τα. Since
the structural relaxation process originates from liquid
structure reorganization, τα is temperature-dependent
and significantly slowed down at low temperatures. Be-
low the glass transition temperature Tg, which is defined
by τα(Tg) = 100 s, the drug stays in a disordered state
for long time, which is larger than the experimental ob-
servation time scale. However, the pharmaceutical can
possibly be recrystallized during manufacturing or stor-
age processes [1, 2]. It turns out that the physical stabil-
ity of many amorphous systems is relatively poor. Com-
prehensive understanding of glassy states and molecular
mobility of amorphous drugs is crucial to formulate phar-
maceutical products having desired properties [1, 2] and
understand fundamentals of glassy state physics.
The relaxation processes of amorphous materials can
be experimentally measured using broadband dielectric
spectroscopy (BDS) and differential scanning calorime-
try (DSC) [1, 2]. BDS technique determines the struc-
tural relaxation time corresponding to thermal variation.
∗Electronic address: anh.phanduc@phenikaa-uni.edu.vn
DSC can measure the glass transition temperature and
analyze phase separation in experimental samples at dif-
ferent cooling rates. The relevant timescale of molec-
ular motions measured by BDS spans from picosecond
above melting temperature to hundreds seconds in vicin-
ity of the glass transition temperature. This technique
can be used to investigate both structural (primary or
long-time) and transient (secondary or short-time) re-
laxation processes.
Recently, the Elastically Collective Nonlinear Langevin
Equation (ECNLE) theory has been developed to un-
derstand structural relaxation time of amorphous sys-
tems [6–11], in which an amorphous material is mod-
eled as a fluid of molecular particles. The ECNLE the-
ory considers a single molecular motion affected by the
nearest-neighbor interactions and cooperative motions of
molecules outside a particle cage formed by the neigh-
boring molecules [6–10]. This physical picture leads to
a local barrier of a dynamic free energy and a collective
barrier for each molecule caused by its nearest-neighbor
interactions and effects of cooperative molecular rear-
rangements, respectively. These barriers are density-
dependent and mutually correlated.
Plugging the two barriers calculated using the ECNLE
theory into Kramer’s theory gives the structural relax-
ation time [6–11]. To find the temperature dependence of
alpha relaxation time, one proposed an analytical conver-
sion (thermal mapping) from averaged particle density to
temperature based on experimental dimensionless com-
pressibility data associated with equation of state [6–10].
The theoretical calculations have also provided quantita-
tive good predictions for the glass transition temperature
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2and dynamic fragility of colloidal systems [8, 9], super-
cooled liquids [7, 9], and polymer melts [6, 10]. However,
the experimental equation-of-state data needed for the
original thermal mapping has rarely measured in amor-
phous drugs. Thus, we have recently proposed another
density-to-temperature conversion using the thermal ex-
pansion and experimental glass transition temperature
values [11]. Our approach has successfully described
temperature-dependent molecular dynamics in one- and
multi-component amorphous drugs.
Most ECNLE calculations have assumed a universal
correlation between local and collective barrier for all
substances when inserting into Kramer’s theory. The
assumption simplifies roles of chemical and biological
complexities on the glass transition. Consequently, the
quantitative agreement between theoretical calculations
and experiments is imperfect. Moreover, since the dy-
namic fragility of a material depends strongly on the form
of τα(T ), a small theory-experiment deviation in τα(T )
leads to an inaccurate prediction of the fragility.
In this work, we introduce an adjustable parameter
characterizing for a non-universal local-collective correla-
tion in pharmaceuticals. The new version of the ECNLE
theory accurately and simultaneously predicts the glass
transition temperature and dynamic fragility of amor-
phous drugs. We employ machine learning technique to
reveal a undiscovered relation between melting point and
glass transition. We also predict the glass transition tem-
perature based on BDS data. Our ECNLE numerical re-
sults are quantitatively compared to experimental data
and machine learning calculations.
Theoretical understanding of how glassy dynamics of
amorphous materials varies with the cooling rate is lim-
ited. Previous theoretical studies [12–14] have given phe-
nological/qualitative descriptions for the Tg change as a
function of cooling rate. Based on the theoretical devel-
opment of this paper, we propose, for the first time, an
analysis to provide quantitative determinations for this
phenomenon and insightful discussions for experiments.
II. STRUCTURAL RELAXATION TIME OF
AMORPHOUS DRUGS
Amorphous drugs/materials are theoretically de-
scribed as a fluid of disconnected spherical rigid particles,
which interact with each other via hard-sphere interac-
tion. The particle diameter is d and the number den-
sity of particles is ρ. A particle is assumingly acted by
three forces including (1) the caging force caused by the
surrounding fluid, -∂Fdyn(r)/∂r, (2) the thermal white
noise, δf , (3) the friction force, −ζs(∂r/∂t), here ζs is a
short-time friction constant and r ≡ r(t) is the displace-
ment of the particle. The key quantity is Fdyn(r) known
as the dynamic free energy of the tagged particle due to
its nearest neighbors [6, 7, 15, 16]. Based on an over-
damped equation-of-motion for the scalar displacement
of a tagged particle, we have
−ζs ∂r
∂t
− ∂Fdyn(r)
∂r
+ δf = 0. (1)
The thermal noise force satisfies 〈δf(0)δf(t)〉 =
2kBTζsδ(t), where kB is the Boltzmann constant and
T is temperature. According to ECNLE theory, the dy-
namic free energy is [6, 7, 15, 16]
Fdyn(r)
kBT
=
∫ ∞
0
dq
q2d3 [S(q)− 1]2
12piΦ [1 + S(q)]
exp
[
−q
2r2(S(q) + 1)
6S(q)
]
− 3 ln r
d
, (2)
where Φ = ρpid3/6 is the volume fraction, q is the
wavevector, and the static structure factor S(q) is cal-
culated using Percus-Yevick (PY) integral equation the-
ory [17] for a hard-sphere fluid. The PY theory ex-
presses S(q) via the direct correlation function C(q) =
[S(q)− 1] /ρS(q). While the fourier transform of C(q) or
the real-space direct correlation function is [17]
C(r) = − (1 + 2Φ)
2
(1− Φ)4 +
6Φ(1 + Φ/2)2
(1− Φ)4
r
d
− Φ(1 + 2Φ)
2
2(1− Φ)4
( r
d
)3
for r ≤ d (3)
C(r) = 0 for r > d. (4)
Recall that the ECNLE theory ignores effects of rota-
tional motions and only consider translational motions,
which are angularly-averaged. The first term of Eq. (2),
which depends strongly on the fluid structure and den-
sity, is the dynamic trapping potential and favors the
particle localization. While the second term independent
of the system structure represents the ideal fluid state.
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FIG. 1: (Color online) A general form of temperature depen-
dence of structural relaxation time described by a coupled
process of local cage-scale dynamics and collective motions.
The dynamic free energy profile of a tagged particle indicates
key length scales and a barrier in the local dynamics.
3Figure 1 shows an illustration of the dynamic free en-
ergy as a function of r and key physical quantities in the
local caging constraint. In dilute suspension (Φ ≤ 0.43)
[15–17], Fdyn(r) monotonically decreases with an in-
crease of r and particles move without constraint. When
Φ > 0.43, the tagged particle is dynamically arrested
within a particle cage formed by its neighbors and one ob-
serves an emergence of a free-energy barrier. The particle
cage radius, rcage, as depicted in Fig. 1 is determined as
the first minimum position in the radial distribution func-
tion, g(r). Since S(q) and g(r) are a Fourier-transform
pair, one has g(r) − 1 = 12pi2ρr
∫∞
0
[S(q)− 1] q sin(qr)dq.
Thus, the radius of the particle cage is about 1.3− 1.5d.
When the dynamic free energy reaches the local mini-
mum and maximum, one obtains the localization length
(rL) and the barrier position (rB). The energy differ-
ence between these two positions is the local hopping
barrier FB = Fdyn(rB) − Fdyn(rL). The jump distance
from the localized position to the barrier position is de-
fined as ∆r = rB − rL. K0 =
∣∣∂2Fdyn(r)/∂r2∣∣r=rL and
KB=
∣∣∂2Fdyn(r)/∂r2∣∣r=rB are absolute curvatures at the
localization length and barrier position.
The rearrangement of particles in the first shell causes
a small expansion on the surface of the particle cage and
generates a harmonic displacement field u(r) in surround-
ing medium via collective motions of other particles. In
bulk systems, one can obtain analytical form of the dis-
tortion field by Lifshitz’s continuum mechanics analysis
[18] (
K +
G
3
)
∇(∇.u) +G∇2u = 0, (5)
where K and G are the bulk and shear modulus, respec-
tively. In Ref. [7, 8], the cage expansion amplitude ∆reff
is found to be
∆reff =
3
r3cage
[
r2cage∆r
2
32
− rcage∆r
3
192
+
∆r4
3072
]
. (6)
Solving Eq. (5) with the boundary condition at the cage
surface gives
u(r) =
∆reffr
2
cage
r2
, r ≥ rcage. (7)
The spatial harmonic displacement energy of a particle
at separation distance r from the center of its arrested
cage is K0u
2(r)/2. Since the local time-averaged density
is ρg(r), the number of particles found at a distance be-
tween r and r + dr is ρg(r)4pir2dr. One can integrate
the elastic energies of particles outside the cage to quan-
tify effects of cooperative motions. The collective elastic
barrier, Fe, is
Fe = 4piρ
∫ ∞
rcage
drr2g(r)K0
u2(r)
2
. (8)
For r ≥ rcage, one can approximate g(r) ≈ 1. The col-
lective motions of molecules play a more important role
than the local dynamics in the glass transition at high
densities or low temperatures [6–8] as depicted in Fig. 1.
The activated relaxation is governed by both local and
non-local processes. If a universal correlation between a
local and non-local process is assumed, the total barrier
is simply Ftotal = FB+Fe. The alpha relaxation time for
a particle to diffuse from its particle cage is quantified by
Kramer’s theory:
τα
τs
= 1 +
2pi√
K0KB
kBT
d2
eFtotal/kBT , (9)
where τs is a short relaxation time scale. The mathemat-
ical form of τs is given by [7, 8]
τs = g
2(d)τE
[
1 +
1
36piΦ
∫ ∞
0
dq
q2(S(q)− 1)2
S(q) + b(q)
]
, (10)
where τE is the Enskog time scale, b(q) =
1/ [1− j0(q) + 2j2(q)], and jn(x) indicates the spherical
Bessel function of order n. Based on many previous stud-
ies of thermal liquids, polymers and amorphous drugs
[6–8, 11], one can assume τE = 10
−13 s.
To convert our hard-sphere calculations into the tem-
perature dependence of the structural relaxation time, we
proposed [11] a thermal mapping, which is based on the
thermal expansion process during temperature variation,
to convert from a volume fraction of hard-sphere fluid to
temperature of experimental material. The mapping is
T ≈ T0 − Φ− Φ0
βΦ0
. (11)
where β is the volume thermal expansion coefficient, Φ0
and T0 are the characteristic volume fraction and tem-
perature, respectively. Since a typical value for linear
thermal expansion coefficient of many glass-forming liq-
uids is 2 − 5 × 10−4 K−1 [19, 20], the volume thermal
expansion coefficient β is approximately 6 − 15 × 10−4
K−1. From a recent work [11], we estimated Φ0 = 0.50
and βΦ0 = 6× 10−4 K−1.
The parameter T0 depends on molar mass and particle
size. Our numerical calculations indicate the structural
relaxation time τα ≈ 100 s at Φ ≈ 0.611. Thus, one
can approximately obtain T0 = Tg − (0.611 − Φ0)/βΦ0.
The experimental value of Tg can be found in many lit-
eratures. Based on the calculation, we investigated the
temperature dependence of the structural relaxation time
of many amorphous drugs and their mixtures (binary
and ternary composites) [11]. The theoretical calcula-
tions without any adjustable parameters quantitatively
agree with various experimental data over 14 decades in
time. While simulations can determine relaxation times
only over first 3-6 decades and do not access experimental
timescale as illustrated in Fig. 1.
Figure 2 shows log10 τα of five representative pure
amorphous drugs [21–24] as a function of 1000/T cal-
culated using Eqs. (9), (10), and (11). Overall, the the-
oretical curves are relatively close to the experimental
4counterpart, except for calculations of vitamin A. A de-
viation of experimental data of the vitamin-A drug from
theoretical calculations is expected. This is because the
theory ignores many chemical and structural complexi-
ties such as hydrogen-bonding, network formers, and flex-
ible molecular docking. Moreover, the approach seems to
provide less quantitatively accurate predictions for the
dynamic fragility of amorphous materials.
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FIG. 2: (Color online) The temperature dependence of struc-
tural relaxation time of chloramphenicol [21], indapamide
[22], ezetimibe [22], biclotymol [23], and vitamin-A acetate
[24]. Open points are experimental data in literatures and
solid curves correspond to our ECNLE calculations.
III. NONUNIVERSAL COUPLING OF LOCAL
AND COOPERATIVE DYNAMICS
The dynamic fragility is calculated by
m =
∂ log10(τα)
∂(Tg/T )
∣∣∣∣
T=Tg
. (12)
One adopts the physical quantity to classify into two
main categories: ”strong” or ”fragile” for glass-forming
materials. For m ≤ 30, the glass formers are strong. The
glass formers having m ≥ 100 are fragile. The remaining
materials are called intermediate glass-forming materials.
The dynamic fragility is very sensitive to the slope of
τα(T ) at T = Tg. Thus, a good agreement between the-
ory and experiment in τα versus T does not mean that
another consistency in calculations of m occurs. In Ref.
[10], authors introduced an adjustable parameter ac to
scale the collective elastic barrier as Fe → a2cFe. The pa-
rameter ac captures chemical and biological complexities,
conformational configuration, and chain connectivity in
different thermal liquids and polymers. The parameter
assesses the relative importance of the collective elastic
distortion by assuming a non-universal coupling of the
cage-scale hopping and collective rearrangements of fluid
particles. The previous work [10] obtained contempora-
neously the quantitative accordance between theoretical
ECNLE calculations and experimental values of both dy-
namic fragility and glass transition temperature for 17
polymers.
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FIG. 3: (Color online) The temperature dependence of struc-
tural relaxation time of twenty-two various amorphous drugs
and polymers listed in Table I [11, 18-39]. Open points are ex-
perimental data in literatures and solid curves correspond to
our ECNLE calculations. PVP is an abbreviation of polyvinyl
pyrrolidone K30.
Motivated by the idea in Ref. [10], in our calculations,
we adjust parameters T0 and ac to achieve the best fit to
the experimental temperature dependence of structural
relaxation times. Figure 3 shows experimental data and
our theoretical calculations for τα(T ) of 22 pure amor-
phous materials. We carry out the same procedure as
calculations in Fig. 2 except for now Ftotal = FB +a
2
cFe.
Our numerical results agree quantitatively well with a
wide range of experimental data. Remarkably, the ac-
tivated events of carvedilol, celecoxib, chloramphenicol,
and polystyrene below Tg, where τα ranges from 100 s to
104 s, are well-described using the ECNLE theory. Many
previous works [26, 27, 43, 44] have observed a distinctive
5Materials Tg(th) (K) Tg(expt) (K) m(th) m(expt) Tm(expt) (K) ac T0 (K)
carvedilol [25] 308 310 [25] 91.5 387.5 [38] 2.1 450
celecoxib [26, 27] 328 328 [26] 97.8 110 [26] 432 [38] 2.1 470
chloramphenicol [21] 301.1 301 [21] 89 116 [21] 423.5 [38] 2.1 443
griseofulvin [28] 358 359 [28] 88.7 84.6 [28] 489 [39] 1.2 533
indomethacin [29] 314.1 315 [29] 86.4 77, 67, 64 [29] 432 [39] 1.5 476
ketoconazole [30] 308 316.3 [30] 71.37 419 [38] 1.0 493
probucol [31] 294 294.7 [31] 79.4 85 [31] 398 [38] 1.5 456
polystyrene [32] 373 373 [10] 105.53 116, 143, 97, 121 [10] 513 [40] 1.7 528
bicalutamide [33] 325.3 325.4 [33] 78.03 84 [33] 464 [39] 1.1 505
biclotymol [23] 288 288 [23] 85.42 85 [23] 2.1 430
polyvinylpyrrolidone K30 [26] 431.2 431 [26] 58.47 70 [26] 523 [41] 0.3 672
tripropyl phosphate [34] 132.1 134 [34] 40.3 194 [38] 2.4 266
vitamin-A acetate [24] 236.3 244.3 [24] 76.6 83 [24] 330 [42] 3.4 349
nisoldipine [35] 303 305 [35] 70.2 81 [35] 425 [42] 1.0 488
nifedipine [35] 315 315 [35] 74.9 84 [35] 444 [39] 1.1 494
nimodipine [35] 284.1 285 [35] 62 82 [35] 398 [38] 0.9 474
indapamide [22] 373.4 373.5 [22] 75.3 73 [22] 433 [38] 0.7 578
ezetimibe [22] 333.3 333.1 [22] 91.1 93 [22] 436 [38] 1.5 495
kollidon VA64 [11] 376.2 378 [11] 79 0.8 573
simvastatin [11] 301 303 [11] 74.8 73 411 [38] 1.3 471
flutamide [36] 272 271 [36] 71.6 385 [38] 1.4 438
ibuprofen [37] 222 225 [37] 68 87 [37] 346 [39] 2.4 356
TABLE I: System parameters and theoretical and experimental results.
deviation, so-called a dynamic structural decoupling, in
the relaxation process at low temperatures. For example,
in Fig. 3a, the growth of τα(T ) of carvediol drug below
Tg is abruptly deviated from what it is supposed to be.
Currently, there is poor theoretical understanding for the
interesting but challenging feature. In the framework of
the ECNLE theory, the decoupling could be related to a
temperature dependence of thermal expansion coefficient
β in our thermal mapping.
From calculations in Fig. 3, we can estimate the glass
transition temperature and dynamic fragility. The local-
nonlocal coupling parameter ac, the characteristic tem-
perature T0, the melting temperature Tm, and theoretical
and experimental values for Tg and m of the studied ma-
terials are listed in Table I. Clearly, the theoretical Tg is
in perfect accordance with the experimental counterpart.
The different accuracy of our calculations for the fragility
is somehow expected and reflects a complicated Tg −m
correlation.
IV. MACHINE-LEARNING BASED ANALYSIS
OF GLASSY DYNAMICS
There are two main methods to obtain Tg from ex-
periments. First, one can use the DSC measurement for
samples to find the value of Tg. Second, experimental-
ists have widely used the Vogel-Fulcher-Tammann (VFT)
equation to fit data measured by the BDS, which is in-
accessible to the deeply supercooled state or (τα ≤ 1s).
From this fitting function, they can obtain the glass tran-
sition temperature at τα = 100 s via extrapolation. How-
ever, the fitting depends strongly on a focused regime of
data [45]. The selection process possibly causes large
overprediction or underprediction of Tg. This is possibil-
ity why many works have reported different Tg values for
a given material.
Here we introduce, for the first time, another approach
based on machine learning techniques. After obtaining a
predictive model by applying the support vector regres-
sion (SVR) in the scikit-learn Python library [54] to ex-
perimental data of the temperature dependence of τα at
high temperatures, we can predict new relaxation times
at lower temperatures than the coolest temperature in
the training dataset. The SVR with the radial basis func-
tion (RBF) kernel has two controlled parameters includ-
ing a regularization parameter CRBF and a RBF kernel
parameter γ. While γ is considered as the inverse of the
standard deviation of the RBF kernel, CRBF determines
the penalty of large slack variables. In our calculations,
we chose γ = 0.1 and obtained equal performance when
CRBF ≥ 100. As shown in Fig. 4, τα(T ) versus 1000/T
predicted by the SVR with CRBF = 10
3 grows smoothly
and are close to experimental data for some representa-
tive amorphous drugs. The number of BDS data points
for simvastatin, ketoconazole, bicalutamide, griseofulvin,
vitamin-A acetate, and nisoldipine used for training are
24, 8, 17, 17, 22, and 28, respectively. The SVR cal-
culations give Tgs for simvastatin, ketoconazole, bicalu-
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FIG. 4: (Color online) The temperature dependence of struc-
tural relaxation time of simvastatin [11], ketoconazole [30],
bicalutamide [33], griseofulvin [28], vitamin-A acetate [24],
and nisoldipine [35]. Open points are experimental data in
literatures and solid curves correspond to machine learning-
based calculations.
tamide, griseofulvin, vitamin-A acetate, and nisoldipine
are 300.2, 308.64, 323, 358.2, 237.8, and 304 K, respec-
tively. These values quantitatively agree experimental
data and our ECNLE results in Table I. This is a new
reliable approach for investigating molecular dynamics
of amorphous materials near Tg, particularly when the
structural decoupling appears [26, 27, 33, 43, 44]. The
linear regression cannot be used in this protocol since it
enforces a Arrhenius nature on any experimental data
and keeps it unchanged in the predictive process.
To find new minimalist correlations or physical insights
among the quantities in Table I, we employ a linear re-
gression model in the scikit-learn library [54]. This re-
gression algorithm provides the simplest relation to de-
scribe a target variable from a set of descriptor vari-
ables. By adopting Tg and Tm experimental values of
71 glassy drugs listed in Ref. [46] as a training dataset,
one obtains Tm ≈ 1.362Tg. It is important to note that
these drugs are different from amorphous materials in
this work. Then, we apply the predicted relation to our
twenty substances to evaluate the validity of the model.
Numerical results in Fig. 5 indicate that the Tg − Tm
correlation works well. This finding suggests the ECNLE
theory can be exploited to estimate the melting temper-
ature with a reasonable deviation.
In many prior works [47–49], the melting point of amor-
phous drugs exhibits an essential role in the solubility de-
termination of the drugs. The linear relation between Tg
and Tm suggests that one can employ ECNLE theory to
evaluate the solubility of amorphous materials and their
mixtures.
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FIG. 5: (Color online) Cross-plot of predicted and experi-
mental values of the melting temperature for all 20 drugs and
polymers from Table I. The blue line indicates perfect agree-
ment.
V. EFFECTS OF COOLING RATE ON GLASSY
DYNAMICS
Although it is experimentally well-known that cooling
rate has considerable impact on glassy dynamics, but the-
oretical understanding has remained ambiguous. Thus,
in this section, we would propose a simple model to esti-
mate how Tg is varied with different cooling rates.
According to an assumption introduced by Cooper and
Gupta in 1982 [12], the molecular relaxation time is ap-
proximately equal to the experimental observation time
at Tg. This assumption leads to a new definition of a
cooling rate, h,
h = −dT
dt
≈ − dT
dτα
. (13)
The minus sign in Eq.(13) represents an inverse variation
between mobility and temperature.
Near glass transition temperature, eFtotal/kBT  1 and
the alpha structural relaxation time in Eq. (9) approxi-
mately becomes
τα(T ) ≈ 2piτs√
K0KB
kBT
d2
eFtotal/kBT . (14)
Recall that the total barrier here is Ftotal = FB + a
2
cFe
as discussed in Section III. After straightforward trans-
formations, one obtains
1
τα
dτα
dT
=
d
dT
ln
(
2piτs√
K0KB
kBT
d2
)
+
d
dT
(
Ftotal
kBT
)
.
(15)
Since τs is order of picoseconds (10
−12 s), the first term
7is much smaller than the second term near Tg. Thus,
hτα(Tg)
d
dT
(
Ftotal
kBT
)∣∣∣∣
T=Tg
≈ −1. (16)
When the temperature dependence of structural relax-
ation time obeys the Arrhenius behavior, the total bar-
rier Ftotal is a constant and our Eq. (16) can be deduced
to be the same mathematical form as previous studies
[13, 14]
hτα(Tg)
Ftotal
kBT 2g
= 1 or
hτα(Tg)
T 2g
= constant. (17)
Moreover, combining Eq. (14) and (16) gives
ln
(
− d
dT
(
Ftotal
kBT
)∣∣∣∣
T=Tg
)
+ ln
(
2piτs√
K0KB
kBTg
d2
)
+
Ftotal
kBTg
+ lnh = 0. (18)
The above equation reveals explicitly a correlation be-
tween the cooling rate and the glass transition tempera-
ture. Recall that various experimental studies have em-
pirically indicated that lnh is linearly proportional to
−1/Tg in a specific range of Tg. If the relation is univer-
sal, it suggests the first two terms in Eq.(18) may play
a minor role compared others and then our analysis can
clearly explain the experimental observation.
Figure 6 shows how the cooling rate influences the
glass transition temperature of polystyrene [50], PVP
[51], nifedipine [52], and indomethacin [51]. Our theo-
retical calculations are relatively consistent with experi-
mental data. Although both theoretical curves and data
points are not perfect straight lines, the rough linear-
ity is possibly observed in a certain range of the glass
transition temperature. One can also crudely view these
smooth curves as a combination of high- and low-Tg lin-
ear branches. Furthermore, as discussed in Section IV,
Tm ≈ 1.362Tg, we expect plotting lnh versus 1000/Tm
(not shown here) does not change the variation trends
compared to Fig. 6. The finding is in accordance with
other experimental works [53].
The effects of cooling rate on Tg can be also analyzed
using the VFT-type relaxation time, which is
τα(T ) = τ0 exp
(
DTV FT
T − TV FT
)
, (19)
where τ0, D, and TV FT are parameters fitted from ex-
perimental data. At T = Tg, we have
hτα(Tg) =
(Tg − TV FT )2
DTV FT
. (20)
Interestingly, both ECNLE theory and VFT-function
analysis give us the same form of the nontrivial corre-
lation among the cooling rate, glass transition tempera-
ture, and fragility
hτα(Tg) =
Tg
m ln(10)
. (21)
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FIG. 6: (Color online) The logarithm of cooling rate as a
function of inverse glass transition temperatures of various
amorphous drugs and polymers. Points are experimental data
and solid curves correspond to our theoretical calculations
using Eq.(16).
For small ln q (≤ 0) or low cooling rates, Tg of polystyrene
is nearly unchanged, approximately 373 K. Thus, one
can utilize the definition of τα(Tg) = 100 s to estimate Tg
in the range of the cooling rate. It suggests that if τα of
all substances is measured at the same low cooling rate,
hτα(Tg) ≈ 100h and Tg is linearly proportional to m.
However, since different experiments have been carried
out at different cooling rates, it is hard to obtain a Tg−m
trivial correlation.
VI. CONCLUSIONS
We have shown several theoretical approaches to im-
prove quantitatively accurate predictions of the glass
transition temperature and dynamic fragility of twenty-
two amorphous drugs and polymers. The temperature
dependence of the structural relaxation time is theoreti-
cally calculated using the version of ECNLE theory. By
introducing an adjustable parameter to describe a non-
universal correlation between local and collective molecu-
lar dynamics in different materials, our numerical results
for the dynamic fragility and Tg measured at various cool-
ing rates show better quantitative agreement with experi-
ments than simply using the universal local-nonlocal cou-
pling. Applying machine-learning calculations to BDS
experimental data gives the same Tg values as using the
VFT fit function. The finding suggests that machine
learning technique can verify the VFT-based results in
all BDS studies instead of comparing with DSC exper-
iments. The machine-learning calculation may be more
reliable to predict Tg and m when the structural decou-
pling of relaxation process occurs. Machine learning also
reveals the linear relation of Tm ≈ 1.362Tg. This relation
explains why the cooling rate changes the melting point
8and glass transition temperature in the same manner.
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